Accumulation of glucose in the bloodstream can lead to hyperglycemia, over time, this condition results in severe health ...

The following is a summary of “Cardiovascular and renal outcomes of glucagon-like peptide 1 receptor agonists among patients with and without type 2 diabetes mellitus: A meta-analysis of randomized ...

People in Scotland may be eligible for Adult Disability Payment to help with daily living or mobility costs as a result of diabetes.

For patients with type 2 diabetes mellitus (T2DM), glucagon-like peptide 1 receptor agonist (GLP-1 RA) use is associated with ...

For patients with type 2 diabetes mellitus (T2DM), glucagon-like peptide 1 receptor agonist (GLP-1 RA) use is associated with ...

November is Diabetes awareness month. Diabetes (Diabetes mellitus) is a common endocrine disorder in all mammals, dogs and cats included. Diabetes is characterized by a dysfunction of insulin ...

This study found that treatment with inebilizumab greatly reduced the symptoms of immunoglobulin G4–related disease (IgG4-RD), compared to placebo.

Dr, Garner said, "Glucagon-like peptide-1 (GLP-1) receptor agonists represent a significant advancement in the treatment of ...

Manoj Chowdary Vattikuti, Sr. DevOps Engineer at Cardinal Health, and Niharikareddy Meenigea, Sr. Data Analyst at Virginia ...

Diabetes mellitus is a chronic metabolic disorder in which the body is not able to control the blood glucose levels in the ...

This review explores the role of lysosomal stress in pancreatic diseases, particularly diabetes mellitus. Lysosomes, crucial ...